rs151317339

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_152743.4(BRAT1):​c.883A>G​(p.Met295Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000535 in 1,610,432 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M295K) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.00037 ( 0 hom., cov: 32)
Exomes š‘“: 0.00055 ( 3 hom. )

Consequence

BRAT1
NM_152743.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 0.734

Publications

2 publications found
Variant links:
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]
BRAT1 Gene-Disease associations (from GenCC):
  • neonatal-onset encephalopathy with rigidity and seizures
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • neurodevelopmental disorder with cerebellar atrophy and with or without seizures
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014736861).
BP6
Variant 7-2543244-T-C is Benign according to our data. Variant chr7-2543244-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 540153.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152743.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAT1
NM_152743.4
MANE Select
c.883A>Gp.Met295Val
missense
Exon 6 of 14NP_689956.2Q6PJG6-1
BRAT1
NM_001350626.2
c.883A>Gp.Met295Val
missense
Exon 6 of 14NP_001337555.1
BRAT1
NM_001350627.2
c.358A>Gp.Met120Val
missense
Exon 5 of 13NP_001337556.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAT1
ENST00000340611.9
TSL:1 MANE Select
c.883A>Gp.Met295Val
missense
Exon 6 of 14ENSP00000339637.4Q6PJG6-1
BRAT1
ENST00000890463.1
c.883A>Gp.Met295Val
missense
Exon 6 of 16ENSP00000560522.1
BRAT1
ENST00000917322.1
c.880A>Gp.Met294Val
missense
Exon 6 of 16ENSP00000587381.1

Frequencies

GnomAD3 genomes
AF:
0.000375
AC:
57
AN:
152022
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000647
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000230
AC:
57
AN:
248196
AF XY:
0.000253
show subpopulations
Gnomad AFR exome
AF:
0.000372
Gnomad AMR exome
AF:
0.0000588
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000419
Gnomad OTH exome
AF:
0.000331
GnomAD4 exome
AF:
0.000551
AC:
804
AN:
1458292
Hom.:
3
Cov.:
31
AF XY:
0.000536
AC XY:
389
AN XY:
725254
show subpopulations
African (AFR)
AF:
0.000210
AC:
7
AN:
33324
American (AMR)
AF:
0.0000677
AC:
3
AN:
44308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26028
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39430
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85984
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52802
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5746
European-Non Finnish (NFE)
AF:
0.000698
AC:
775
AN:
1110468
Other (OTH)
AF:
0.000282
AC:
17
AN:
60202
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
45
91
136
182
227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000375
AC:
57
AN:
152140
Hom.:
0
Cov.:
32
AF XY:
0.000309
AC XY:
23
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41508
American (AMR)
AF:
0.0000654
AC:
1
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000647
AC:
44
AN:
67980
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000458
Hom.:
0
Bravo
AF:
0.000348
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000181
AC:
22
EpiCase
AF:
0.000600
EpiControl
AF:
0.000714

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Neonatal-onset encephalopathy with rigidity and seizures (1)
-
1
-
Neonatal-onset encephalopathy with rigidity and seizures;C4748032:Neurodevelopmental disorder with cerebellar atrophy and with or without seizures (1)
-
1
-
Neurodevelopmental disorder with cerebellar atrophy and with or without seizures (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.050
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
2.4
DANN
Benign
0.41
DEOGEN2
Benign
0.00093
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.0056
N
LIST_S2
Benign
0.22
T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.015
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.69
N
PhyloP100
0.73
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.15
N
REVEL
Benign
0.076
Sift
Benign
0.50
T
Sift4G
Benign
0.61
T
Polyphen
0.0
B
Vest4
0.091
MVP
0.32
MPC
0.046
ClinPred
0.0047
T
GERP RS
4.0
Varity_R
0.037
gMVP
0.17
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151317339; hg19: chr7-2582878; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.